Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,164,909 papers from all fields of science
Search
Sign In
Create Free Account
Lanoxicaps
Known as:
GlaxoSmithKline Brand 2 of Digoxin
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Digoxin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Comparison of Steady-State Serum Concentrations of Digoxin in Tablets (Lanoxin) and Capsules (Lanoxicaps) in the Elderly
M. Pouwels
,
P. Hooymans
,
G. C. van der Aa
,
F. Gribnau
DICP : the annals of pharmacotherapy
1991
Corpus ID: 33974403
The bioavailability of digoxin in solution (Lanoxicaps, 90–100 percent) is superior to that of Lanoxin tablets (60–80 percent) in…
Expand
1984
1984
Lanoxicaps: a new digoxin formulation with improved bioavailability.
D. Brown
Iowa medicine : journal of the Iowa Medical…
1984
Corpus ID: 7901580
1983
1983
Digoxin solution in capsules (Lanoxicaps).
The Medical letter on drugs and therapeutics
1983
Corpus ID: 39568494
1981
1981
The effects of some organic solvents on the absorption of digoxin by man.
A. Fowle
,
J. French
,
J. O'grady
Arzneimittel-Forschung
1981
Corpus ID: 34870990
Ten healthy subjects took each of 6 different solutions of 0.5 mg digoxin in a study of the effect of different solvents on…
Expand
1977
1977
The comparability of dosage regimens of Lanoxin tablets and Lanoxicaps.
B. Johnson
,
G. Smith
,
J. French
British Journal of Clinical Pharmacology
1977
Corpus ID: 19917733
1 Twice daily administration of 0.25 mg digoxin tablets (Lanoxin) or of 0.2 mg digoxin in solution in soft gelatin capsules…
Expand